Abstract:Objective To investigate the effects of FK506-binding protein 4 (FKBP4) on the migration, invasion and apoptosis of prostate cancer DU145 cells.Methods Differences in FKBP4 expression between prostate cancer tissues and adjacent normal tissues were compared using the Tumor Immune Estimation Resource 2.0 (TIMER2.0) database. Quantitative real-time polymerase chain reaction (qRT-PCR) and Western blotting were used to detect FKBP4 expression levels in different prostate cancer cell lines (DU145, PC3, LNCaP) and normal prostate epithelial cells (RWPE-1). Prostate cancer DU145 cells were divided into three experimental groups: a blank control group, an si-NC group, and an si-FKBP4 group. Cell migration activity of DU145 cells was analyzed using the cell scratch assay. Invasion capacity was assessed via the Transwell assay. The apoptosis rates were determined using TUNEL staining. The expression levels of FKBP4, phosphoinositide 3-kinase (PI3K) and protein kinase B (Akt) in DU145 cells were detected by Western blotting and qRT-PCR.Results Analysis using the TIMER2.0 database revealed that the mRNA expression levels of FKBP4 were significantly higher in prostate cancer tissues compared to adjacent normal prostate tissues (P < 0.05). Compared with the RWPE-1 group (normal human prostate epithelial cells from the TIMER 2.0 database), the relative mRNA and protein expression levels of FKBP4 were significantly increased in the DU145 group (human prostate cancer DU145 cells), PC3 group (human prostate cancer PC3 cells), and LNCaP group (human prostate cancer LNCaP cells) (all P < 0.05). Compared with the blank control group and the si-NC group, the si-FKBP4 group exhibited decreased migration and invasion abilities of DU145 cells, along with an increased apoptosis rate (P < 0.05). Furthermore, compared with the blank control group and the si-NC group, the si-FKBP4 group showed significantly reduced relative mRNA and protein expression levels of FKBP4, PI3K, and Akt in DU145 cells (P < 0.05).Conclusion FKBP4 is up-regulated in prostate cancer and influences the migration, invasion and apoptosis of DU145 cells via the PI3K/Akt signalling pathway.